Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NOVARTIS INDIA LTD.

NSE : NOVARTINDBSE : 500672ISIN CODE : INE234A01025Industry : TradingHouse : Novartis India - MNC

BSE865.009.4 (+1.1 %)

PREV CLOSE ( ) 855.60

OPEN PRICE ( ) 859.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4316

TODAY'S LOW / HIGH ( )837.00 869.60

52 WK LOW / HIGH ( )829 1248

NSE672.250 (0 %)

PREV CLOSE( ) 672.25

OPEN PRICE ( ) 691.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 672.25 (249)

VOLUME 11837

TODAY'S LOW / HIGH( ) 668.35 698.20

52 WK LOW / HIGH ( )668.35 698.2

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-12 1947

Management Info

Christopher Snook - Chairman - Managing Director

Registered Office

Address The Inspire B K C, 7th Floor,Bandra Kurla Complex,Bandra (East),
Mumbai,
Maharashtra-400051

Phone 022-50243000

Email india.investors@novartis.com

Website www.novartis.in

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

04Jul Novartis India informs about loss of s
Novartis India has informed that it enclosed intimation under regulation..

15May Novartis India informs about loss of s
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

10May Novartis India informs about board mee
In continuation to intimation dated March 27, 2024 and pursuant to Regul..

08May Novartis India informs about change in
Novartis India has informed that based on the recommendation of Nominati..

19Mar Novartis India informs about details o
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

Financials

Rs. in Millions

	QTR Sep 24	ANNUAL 24
Net Profit	204.1	851.9
Gross Profit	275.6	1228.4
Operating Profit	282.8	1269.4
Net Sales	871	3350.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kemp & Company (BSE) 1452.40 (4.94%)	M.Cap ( in Cr)156.89
Thacker & Co (BSE) 1775.00 (1.87%)	M.Cap ( in Cr)193.07
Halder Venture (BSE) 663.40 (3.65%)	M.Cap ( in Cr)275.05
Simplex Papers (BSE) 2100.00 (0.91%)	M.Cap ( in Cr)6.30
MSTC (BSE) 634.45 (2.87%)	M.Cap ( in Cr)4466.53

Shareholding Pattern

	PROMOTERS	70.68%
	NON-INSTITUTION	28.61%
	FI/BANKS/INSURANCE	0.52%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bandhan BSE Healthc...	0.05
Motilal Oswal BSE H...	0.05

Risk Disclosures on Derivatives

Smart Quotes

NOVARTIS INDIA LTD.